CEOs from AI companies, including Sam Altman of OpenAI, Demis Hassabis of Google DeepMind, and Dario Amodei of Anthropic, along with 85 other experts, have signed an open letter advocating for stricter regulations on gene synthesis. Their concerns center on the potential misuse of AI in developing biological weapons through gene synthesis, a process that allows for the creation of custom DNA sequences in laboratories.
Gene synthesis has been instrumental in advancements such as vaccines and gene therapies, but it also poses risks, as the same technology could be used to create harmful pathogens. Currently, U.S. companies offering gene synthesis services voluntarily screen orders for potentially dangerous genetic sequences, but not all providers adhere to these standards. Experts warn that without mandatory regulations, there is a risk that bad actors could exploit more lenient companies.
The letter calls for Congress to implement mandatory screening and recordkeeping for gene synthesis orders to enhance biosecurity. It emphasizes the importance of traceability in preventing misuse and highlights the need for a unified national standard for gene synthesis regulations. The signatories believe that proactive measures are necessary to mitigate the risks associated with AI-assisted gene synthesis technology.